Introduction {#S0001}
============

Demarcation-laser photocoagulation (DLP) is a method that can be used to treat rhegmatogenous retinal detachments (RRDs) by forming a barrier possibly to reduce the chance of further extension of subretinal fluid.[@CIT0001]--[@CIT0003] This method of management has been reported for macula-sparing RRD without visual field loss.[@CIT0002] It is less invasive than scleral buckling or vitrectomy, and has the advantage of being time-efficient and inexpensive, as it can be performed easily in the outpatient clinic.[@CIT0004] The authors present three patients in which DLP was used to barricade asymptomatic macular-sparing RRDs, and stability was achieved over follow-up of 3--10 years.

Case reports {#S0002}
============

Case 1 {#S0002-S2001}
------

A 67-year-old male presented with an asymptomatic RRD of the right eye in 2015, was treated with DLP, and subsequently underwent cataract surgery. Three years later in 2018, he presented with worsening vision and distortion in the right eye, with best-corrected visual acuity (BCVA) of 20/200 OD and 20/20 OS. On dilated-fundus exam, there was a macular epiretinal membrane with drusen, as well as stability of the laser-barricaded shallow temporal RD extending from 7 to 11 o'clock, with no breaks evident ([Figure 1](#F0001){ref-type="fig"}). The patient underwent pars plana vitrectomy with membrane peeling, and subsequent BCVA was 20/30 1 month after surgery. The postoperative exam 1 month later showed stability of the laser-demarcated RD.Figure 1Case 1: 3-year follow-up of temporal rhegmatogenous retinal detachment treated with demarcation-laser photocoagulation.

Case 2 {#S0002-S2002}
------

A 57-year-old male had had treatment for an asymptomatic chronic RRD of the right eye with DLP and 10 years of follow-up. Upon presentation, BCVA was 20/30 OD, 20/20 OS. Refraction was −6.50 Sph OD and −7.50 Sph OS. The patient was phakic, and on dilated exam there was posterior vitreous detachment with shallow temporal RD extending from 7 to 11 o'clock with no breaks evident, surrounded with laser barricade, as well as a mild epiretinal membrane. Three years later in 2018, the patient had stable vision, and the previous temporal RD in the right eye was noted to be spontaneously resolved, with remaining pigment changes ([Figure 2](#F0002){ref-type="fig"}).Figure 2Case 2: 10-year follow-up of temporal rhegmatogenous retinal detachment treated with demarcation-laser photocoagulation.

Case 3 {#S0002-S2003}
------

A 50-year-old male with a history of myopia after photorefractive keratectomy presented with a non-ischemic central retinal vein occlusion and cystoid macular edema in the left eye. The macular edema was being treated with intravitreal bevacizumab. The patient was phakic and noted to have posterior vitreous detachment with an asymptomatic temporal horseshoe tear at 2:30 and surrounding shallow subretinal fluid extending from 2 to 4 o'clock, for which he received laser demarcation. BCVA was 20/20 OD, 20/30 OS. Three years later, the laser-barricaded RD in the left eye had not progressed, and BCVA remained at 20/30 ([Figure 3](#F0003){ref-type="fig"}).Figure 3Case 3: 3-year follow-up of temporal rhegmatogenous retinal detachment treated with demarcation-laser photocoagulation.

Discussion {#S0003}
==========

While vitreoretinal surgery is used to manage nearly all macula-sparing RRDs, the use of DLP can be considered for a subset of these detachments, particularly those that are asymptomatic. DLP has been in use since 1968, when Okun and Cibis recommended photocoagulation for limited RDs defined by size.[@CIT0005] The described criteria included width at least twice but not greater than five times the diameter of the largest break, and less than 2 clock hours in size with the posterior extent not beyond the equator. On the other hand, some authors have recommended observation for subclinical or asymptomatic RRDs. In a study by Byer,[@CIT0006] only three of 18 asymptomatic detachments progressed during follow-up of 1--18 years, with none requiring surgery. Likewise, Brod et al[@CIT0007] reported a series of 29 of 31 eyes with asymptomatic RDs that did not progress over a mean 3.4 years\' follow-up.

While macula-sparing RRDs can be asymptomatic, many RRDs with demarcation lines or caused by round holes may remain stable without progression. However, some studies have reported that even low-risk RRDs may progress.[@CIT0006],[@CIT0008],[@CIT0009] In particular, Al-Mohtaseb et al[@CIT0004] found that 38.5% of patients with symptomatic RDs treated with DLP required further intervention secondary to progression. Because laser photocoagulation enhances retinal adhesion, it may be an effective treatment for asymptomatic RDs.[@CIT0002],[@CIT0003] Vrabec and Baumal[@CIT0002] found DLP to be an effective treatment, with only one of 34 detachments (2.9%) progressing beyond the laser barrier, and progression was attributable to incomplete demarcation. The primary feature shared among detachments stabilized with DLP was a shallow, relatively tense appearance without associated corrugations. The three cases presented in the current series demonstrate the typical shallow, nonbullous RDs that remained stable over the long term. Interestingly, spontaneous resolution of RD, as seen in case 2, has been previously reported.[@CIT0006],[@CIT0010] One hypothesized mechanism for this would be detached posterior vitreous plugging of the retinal break.[@CIT0011]

In conclusion, these three cases demonstrate the stability of DLP for asymptomatic macula-sparing RRDs, all of which were shallow and without corrugations. For this subset of RDs, DLP may be a viable option for patients uncomfortable with observation alone, who have limited access to health care, or who are not candidates for surgery because of systemic comorbidities.
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